143 related articles for article (PubMed ID: 30845890)
1. Prior Amiodarone Exposure Reduces Tacrolimus Dosing Requirements in Heart Transplant Recipients.
Breslin NT; Salerno DM; Topkara VK; Latif F; Restaino S; Takeda K; Takayama H; Farr M; Colombo PC; Jennings DL
Prog Transplant; 2019 Jun; 29(2):129-134. PubMed ID: 30845890
[TBL] [Abstract][Full Text] [Related]
2. Amiodarone-sirolimus/tacrolimus interaction in a pediatric heart transplant patient.
Nalli N; Stewart-Teixeira L; Dipchand AI
Pediatr Transplant; 2006 Sep; 10(6):736-9. PubMed ID: 16911499
[TBL] [Abstract][Full Text] [Related]
3. Clinically Significant Drug Interaction Between Clotrimazole and Tacrolimus in Pancreas Transplant Recipients and Associated Risk of Allograft Rejection.
Viesselmann CW; Descourouez JL; Jorgenson MR; Radke NA; Odorico JS
Pharmacotherapy; 2016 Mar; 36(3):335-41. PubMed ID: 26877191
[TBL] [Abstract][Full Text] [Related]
4. Amiodarone-tacrolimus interaction in kidney transplantation.
Kisters K; Cziborra M; Funke C; Brylak S; Hausberg M
Clin Nephrol; 2008 Dec; 70(6):563. PubMed ID: 19049720
[No Abstract] [Full Text] [Related]
5. Association Between Time-in-Therapeutic Tacrolimus Range and Early Rejection After Heart Transplant.
Baker WL; Steiger S; Martin S; Patel N; Radojevic J; Darsaklis K; O'Bara L; Kutzler H; Dougherty J; Feingold A; Hammond J; Fusco D; Gluck JA
Pharmacotherapy; 2019 May; 39(5):609-613. PubMed ID: 30892740
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus Concentration-to-Dose Ratios in Kidney Transplant Recipients and Relationship to Clinical Outcomes.
Bartlett FE; Carthon CE; Hagopian JC; Horwedel TA; January SE; Malone A
Pharmacotherapy; 2019 Aug; 39(8):827-836. PubMed ID: 31230376
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent association between amiodarone and severe primary graft dysfunction in orthotopic heart transplantation.
Wright M; Takeda K; Mauro C; Jennings D; Kurlansky P; Han J; Truby L; Stein S; Topkara V; Garan AR; Yuzefpolskaya M; Colombo P; Naka Y; Farr M; Takayama H
J Heart Lung Transplant; 2017 Nov; 36(11):1226-1233. PubMed ID: 28583372
[TBL] [Abstract][Full Text] [Related]
8. Once- vs Twice-Daily Tacrolimus: Survival Rates and Side Effects: Single-Center Experience.
Turunc V; Ari E; Guven B; Tabendeh B; Yildiz A
Transplant Proc; 2019 Sep; 51(7):2308-2311. PubMed ID: 31400977
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of tacrolimus in patients with steroid-resistant cardiac allograft cellular rejection.
Yamani MH; Starling RC; Pelegrin D; Platt L; Majercik M; Hobbs RE; McCarthy P; Young JB
J Heart Lung Transplant; 2000 Apr; 19(4):337-42. PubMed ID: 10775813
[TBL] [Abstract][Full Text] [Related]
11. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil.
Dipchand AI; Pietra B; McCrindle BW; Rosebrook-Bicknell HL; Boucek MM
J Heart Lung Transplant; 2001 Oct; 20(10):1035-43. PubMed ID: 11595558
[TBL] [Abstract][Full Text] [Related]
13. To use or not to use? Amiodarone before heart transplantation.
Lushaj EB; Dhingra R; Chindhy S; Akhter S; Kohmoto T; Ulschmid S; Osaki S; Badami A; Lozonschi L
Surgery; 2017 May; 161(5):1273-1278. PubMed ID: 27876282
[TBL] [Abstract][Full Text] [Related]
14. Effects of clotrimazole troches on tacrolimus dosing in heart transplant recipients.
Laub MR; Crow SA; Personett HA; Dierkhising R; Boilson B; Razonable R
Transpl Infect Dis; 2018 Dec; 20(6):e12979. PubMed ID: 30120865
[TBL] [Abstract][Full Text] [Related]
15. Prospective clinical trial comparing two immunosuppressive regimens, tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine, in de novo renal transplant recipients: results at 6 months follow-up.
Favi E; Citterio F; Spagnoletti G; Gargiulo A; Delreno F; Romagnoli J; Castagneto M
Transplant Proc; 2009 May; 41(4):1152-5. PubMed ID: 19460503
[TBL] [Abstract][Full Text] [Related]
16. Impact of pre-implant amiodarone exposure on outcomes in cardiac transplant recipients.
Jennings DL; Martinez B; Montalvo S; Lanfear DE
Heart Fail Rev; 2015 Sep; 20(5):573-8. PubMed ID: 25925244
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients.
Onsager DR; Canver CC; Jahania MS; Welter D; Michalski M; Hoffman AM; Mentzer RM; Love RB
J Heart Lung Transplant; 1999 May; 18(5):448-55. PubMed ID: 10363689
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up.
Ciancio G; Burke GW; Gaynor JJ; Roth D; Sageshima J; Kupin W; Tueros L; Hanson L; Rosen A; Ruiz P; Miller J
Transplantation; 2008 Jul; 86(1):67-74. PubMed ID: 18622280
[TBL] [Abstract][Full Text] [Related]
19. [Tacrolimus blood levels and incidence of graft rejection in heart transplantation].
Albornoz López R; Aumente Rubio MD; Arizón Del Prado JM; Cárdenas Aranzana M; López Malo de Molina MD; Gago Sánchez AI
Farm Hosp; 2005; 29(3):158-63. PubMed ID: 16013941
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
Miller J; Mendez R; Pirsch JD; Jensik SC
Transplantation; 2000 Mar; 69(5):875-80. PubMed ID: 10755543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
